What the name refers to
A long-acting CJC-1295 form designed to bind albumin through a drug-affinity-complex moiety.
Evidence and regulatory context
Human clinical research exists, but this entry is not a broadly authorised consumer medicine. Trial results apply to the studied formulation, population and endpoints—not automatically to products sold online.
Reading product records
The record should distinguish a regulated medicine from a research-labelled analogue and state the exact molecule. For injectables, identity and quantity do not replace sterility, endotoxin, storage and batch-traceability information.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.